Literature DB >> 20471736

Immunoglobulin deposition disease with a membranous pattern and a circulating monoclonal immunoglobulin G with charge-dependent aggregation properties.

Sophie de Seigneux1, Pascal Bindi, Hanna Debiec, Marie-Alexandra Alyanakian, Bernadette Aymard, Patrice Callard, Pierre Ronco, Pierre Aucouturier.   

Abstract

A 62-year-old woman presented with nephrotic syndrome, monoclonal gammopathy, and membranous-like nephropathy with nonorganized deposits composed of monoisotypic immunoglobulin G1 lambda protein. Nephrotic syndrome remitted after a brief course of treatment with melphalan despite ongoing production of the monoclonal protein. The circulating monoclonal immunoglobulin G1 lambda showed unusual in vitro aggregation properties, including dependence on low ionic strength and neutral pH, suggesting that electrostatic interactions had a role in the precipitation process. This case illustrates the importance of looking for monoclonal immunoglobulin deposits when kidney biopsy findings are suggestive of membranous nephropathy. In addition, our in vitro demonstrations of the role of physicochemical factors in immunoglobulin precipitation help elucidate the pathogenesis of immunoglobulin deposition disorders. Although binding to podocyte antigens is a well-recognized determinant of subepithelial immunoglobulin deposition, proneness to aggregation as described in this case also might be nephritogenic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471736     DOI: 10.1053/j.ajkd.2010.03.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

1.  Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft.

Authors:  Samih H Nasr; Sanjeev Sethi; Lynn D Cornell; Mary E Fidler; Mark Boelkins; Fernando C Fervenza; Fernando G Cosio; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

Review 2.  Immunopathogenesis of membranous nephropathy: an update.

Authors:  Hanna Debiec; Pierre Ronco
Journal:  Semin Immunopathol       Date:  2014-04-09       Impact factor: 9.623

3.  Monoclonal gammopathy associated membranous glomerulonephritis: A rare entity.

Authors:  K K Gowda; K Joshi; R Ramachandran; R Nada
Journal:  Indian J Nephrol       Date:  2015 Jan-Feb

4.  Non-Randall proliferative glomerulonephritis with humps and monotypic IgG deposits in primary Sjögren's syndrome: a first case report.

Authors:  Karine Dahan; Catherine Albert; Jean-Benoît Arlet; Patrice Callard; Pierre Ronco
Journal:  NDT Plus       Date:  2010-09-01

5.  A Case of Proliferative Glomerulonephritis with Monoclonal IgG Deposits That Showed Predominantly Membranous Features.

Authors:  Homare Shimohata; Kentaro Ohgi; Hiroshi Maruyama; Yasunori Miyamoto; Mamiko Takayashu; Kouichi Hirayama; Masaki Kobayashi
Journal:  Case Rep Nephrol       Date:  2017-10-25

6.  Development of Renal Failure without Proteinuria in a Patient with Monoclonal Gammopathy of Undetermined Significance: An Unusual Presentation of AL Kappa Amyloidosis.

Authors:  Yijuan Sun; Amarpreet Sandhu; Darlene Gabaldon; Jonathan Danaraj; Karen S Servilla; Antonios H Tzamaloukas
Journal:  Case Rep Nephrol       Date:  2012-10-02

7.  Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts.

Authors:  Laith Al-Rabadi; Jean M Francis; Joel Henderson; Sandeep Ghai
Journal:  Clin Kidney J       Date:  2015-11-03

8.  Membranous Glomerulopathy With Light Chain-Restricted Deposits: A Clinicopathological Analysis of 28 Cases.

Authors:  Alejandro Best Rocha; Christopher P Larsen
Journal:  Kidney Int Rep       Date:  2017-07-29

9.  Proliferative glomerulonephritis with monoclonal IgG deposits; an unusual cause of de novo disease in kidney allograft.

Authors:  Sabiha M Hussain; Kalathil K Sureshkumar
Journal:  J Nephropathol       Date:  2017-04-05

10.  An IgA1-lambda-type monoclonal immunoglobulin deposition disease associated with membranous features in a patient with IgG4-related kidney disease: a case report.

Authors:  Atsushi Kitazawa; Ryo Koda; Atsunori Yoshino; Yoshihiko Ueda; Tetsuro Takeda
Journal:  BMC Nephrol       Date:  2018-11-20       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.